Covered recipient · General Payments record
ABDULMUTTALEB AL SOUFI
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2021–2024
$257.53
- Reported across 12 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $151.58 | 9 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Acerta Pharma LLC | $30.69 | 2 |
| PFIZER INC. | $29.44 | 1 |
| GlaxoSmithKline, LLC. | $29.13 | 2 |
| DEXCOM, INC. | $18.11 | 1 |
| Abbott Laboratories | $15.41 | 1 |
| Amgen Inc. | $14.46 | 1 |
| Lilly USA, LLC | $14.34 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (9)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Abbott Laboratories | $15.41 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1125341193 | CMS |
| Amgen Inc. | $14.46 | 01/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117186438 | CMS |
| AstraZeneca Pharmaceuticals LP | $16.36 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105852270 | CMS |
| AstraZeneca Pharmaceuticals LP | $14.33 | 08/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105810113 | CMS |
| Dexcom, Inc. | $18.11 | 02/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1153276002 | CMS |
| GlaxoSmithKline, LLC. | $15.92 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116509683 | CMS |
| GlaxoSmithKline, LLC. | $13.21 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116237016 | CMS |
| Lilly USA, LLC | $14.34 | 10/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1136001467 | CMS |
| PFIZER INC. | $29.44 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131025177 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.